PLGA/TPGS Nanoparticles for Controlled Release of Paclitaxel: Effects of the Emulsifier and Drug Loading Ratio

Pharmaceutical Research

Volumn 20, Issue 11, 2003, Pages 1864-1872

  Mu, Li ^a   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anti cancer agent; Biodegradable polymer; D tocopheryl polyethylene glycol 1000 succinate; Drug delivery; Emulsifier; Taxol

Indexed keywords

EMULSIFYING AGENT; NANOPARTICLE; PACLITAXEL; POLYGLACTIN; POLYMER; POLYVINYL ALCOHOL; TOCOFERSOLAN;

ARTICLE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; DRUG FORMULATION; DRUG MANUFACTURE; EVAPORATION; MICROENCAPSULATION; PRIORITY JOURNAL; PRODUCTIVITY; SOLVENT EXTRACTION; STATISTICAL SIGNIFICANCE;

DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; EMULSIFYING AGENTS; LACTIC ACID; NANOTECHNOLOGY; PACLITAXEL; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS; VITAMIN E;

EID: 0344083669     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000003387.15428.42     Document Type: Article

References (30)

1. K. S. Soppimath, T. M. Aminabhavi, A. R. Kulkarni and W. E. Rudzinski, Biodegradable polymeric nanoparticles as drug delivery devices, J. Control Rel. 70:1-20 (2001).
2. S. M. Moghimi, A. C. Hunter, and J. C. Murray. Long-circulating and target specific nanoparticles: theory to practice. Pharmacol. Rev. 53:283-318 (2001).
3. R. Langer. Biomaterials in drug delivery and tissue engineering: one laboratory's experience. Acc. Chem. Res. 33(2):94-101 (2000).
4. C. X. Songa, V. Labhasetwara, H. Murphya, X. Qua, W. R. Humphreyb, R. J. Shebuskib and R. J. Levy. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery, J. Control Rel. 43:197-212 (1997).
5. V. Labhasetwar. Nanoparticles for drug delivery. Pharm. News. 4:28-31 (1997).
6. J. Couzin. Cancer Research: nanoparticles cut tumors. Science 296:2314-2315 (2002).
7. J. D. Hood, M. Bednarski, R. Frausto, S. Guccione, R. A. Reisfeld, R. Xiang, and D. A. Cheresh. Tumor Regression by Targeted Gene Delivery to the Neovasculature. Science 296:2404-2407 (2002).
8. V. Labhasetwar, C. Song, and R. J. Levy. Nanoparticle drug delivery system for restenosis. Adv. Drug Delivery Rev. 24:63-85 (1997).
9. R. H. Muller, (ed.), Colloidal Carriers for Controlled Drug Delivery and Targeting, CRC Press. Boca Raton, Florida. 1991, pp. 1-16.
10. P. D. Scholes, A. G. A. Coombes, L. Illum, et al. The preparation of sub-200 nm poly (lactide-co-glycolide) microspheres for site-specific drug delivery. J. Control Rel. 25:145-153 (1993).
11. M. F. Zambaux, F. Bonneaux, R. Gref et al. Influence of experimental parameters on the characteristics of poly (lactic acid) nanoparticles prepared by a double emulsion method. J. Control. Rel. 50:31-40 (1998).
12. A. Carrio, G. Schwach, J. Coudane, and M. Vert. Preparation and degradation of surfactant-free PLGA microspheres. J. Control Rel 37:113-121 (1991).
13. S. C. Lee, J. T. Oh, M. H. Jang, and S. Chung. Quantitative analysis of poly vinyl alcohol on the surface of poly(D,L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: effect of particle size and PVA concentration. J. Control Rel. 59:123-132 (1999).
14. D. T. Birnbaum, J. D. Kosmala, and L. Brannon-Peppas. Optimization of preparation techniques for poly(lactic acid-co-glycolide acid) nanoparticles. J. Nanoparticle Res. 2:173-181 (2000).
15. D. Quintanar-Guerrero, H. Fessi, E. Allemann, and E. Doelker. Influence of stabilizing agents and preparative variables on the formation of poly(D,L-lactic acid) nanoparticles by an emulsification-diffusion technique. Int. J. Pharmaceutics 143:133-141 (1996).
16. M. F. Zambaux, F. Bonneaux, R. Gref, P. Maincent, E. Dellacherie, M. J. Alonso, P. Labrude, and C. Vigneron. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J. Control Rel. 50:31-40 (1998).
17. R. Gref, V. Babak, P. Bouillot, I. Lukina, M. Bodorev, and E. Dellacherie. Interfacial and emulsion stabilizing properties of amphiphilic water-soluble poly(ethylene glycol)-poly(lactic acid) copolymers for the fabrication of biocompatible nanoparticles. Colloids and Surfaces. A. Physicochemical and Engineering Aspects 143:413-420 (1998).
18. S. K. Sahoo, J. Panyam, S. Prabha, and V. Labhasetwar. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J. Controlled Release 82(1):105-114 (2002).
19. A. K. Singla, G. Alka, and A. Deepika. Paclitaxel and its formulations. Int. J. Pharmaceutics 235:179-192 (2002).
20. E. Tatou, C. Mossiat, V. Maupoil, F. Gabrielle, M. David, and L. Rochette. Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation. Pharmacol. 52:1-7 (1996).
21. R. T. Dorr. Pharmacology and toxicology of Cremophor EL diluent. Ann. Pharmacother. 28:S11-S14 (1994).
22. M. L. Fjallskog, L. Frii, and J. Bergh. Is cremophor, solvent for paclitaxel, cytotoxic? Lancet 342:873 (1993).
23. L. Mu and S. S. Feng. A novel controlled release formulation for anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. J. Control. Rel. 86:33-48 (2003).
24. Y. N. Konan, R. Gurny, and E. Allemann. Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int. J. Pharmaceutics 233:239-252 (2002).
25. H. Murakami, Y. Kawashima, T. Niwa, T. Hino, H. Takeuchi, and M. Kobayashi. Influence of the degrees of hydrolyzation and polymerization of poly(vinylalcohol) on the preparation and properties of poly(DL-lactide-co- glycolide) nanoparticle. Int. J. Pharmaceutics 149:43-49 (1997).
26. H. Murakami, M. Kobayashi, H. Takeuchi, and Y. Kawashima, Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharmaceutics 187:143-152 (1999).
27. C. Dubernet. Thermoanalysis of microspheres. Thermochimica Acta 248:259-269 (1995).
28. P. D. Scholes, A. G. A. Coombes, L. Ilium, S. S. Davis, J. F. Watts, C. Ustariz, M. Vert, and M. C. Davies. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J. Control Rel. 59:261-278 (1999).
29. D. Briggs and M. P. Seah. (eds), Practical Surface Analysis by Auger and X-ray Photoelectron Spectroscopy, John Wiley, Chichester, 1990.
30. T. Corner, R. Gref, D. Michenot, F. Sommer, M. N. Tran, and E. Dellacherie. Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix. J. Control. Rel. 57:259-268 (1999).